ברינרט
csl behring ltd., israel - c - 1 esterase inhibitor human - אבקה להמסה להזרקה\אינפוזיה - c - 1 esterase inhibitor human 500 iu/vial - c1- inhibitor,plasma derived - c1- inhibitor,plasma derived - hereditary angioedema type i and ii (hea) , treatment of acute episodes.
לבטיראצטם טבע ® 250 מ"ג
teva pharmaceutical indust.ltd - levetiracetam 250 mg - tablets - levetiracetam - - levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.- levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.
לבטיראצטם טבע ® 500 מ"ג
teva pharmaceutical indust.ltd - levetiracetam 500 mg - tablets - levetiracetam - - levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.- levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.
לבטיראצטם טבע ® 1000 מ"ג
teva pharmaceutical indust.ltd - levetiracetam 1000 mg - tablets - levetiracetam - - levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.- levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.
סופראמוקס s.p וטרינרי
romat ltd - amoxicillin as trihydrate - אבקה להכנת תמיסה - amoxicillin as trihydrate 700 mg/g - treatment of infections due to microorganisms sensitive to amoxicillin in broilers.
אוקסטרה וטרינרי
romat ltd - oxytetracycline hydrochloride - התקן תוך נרתיקי - oxytetracycline hydrochloride 1 g
אמפיווט וטרינרי
romat ltd - ampicillin as sodium - אבקה להכנת תמיסה - ampicillin as sodium 75 g / 100 g
דודיסיל וטרינרי
romat ltd - cyanocobalamin; thiamine (vit b1) hydrochloride - תמיסה להזרקה - cyanocobalamin 1 mg/ml; thiamine (vit b1) hydrochloride 100 mg/ml
מיקוספקטונה וטרינרי
romat ltd - lincomycin hydrochloride; spectinomycin hydrochloride - תמיסה להזרקה - spectinomycin hydrochloride 150 mg/ml; lincomycin hydrochloride 56.7 mg/ml